Ligand validation:6SLL

DAB: 2,4-DIAMINOBUTYRIC ACID

DAB is a Ligand Of Interest in 6SLL designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6SLL_DAB_A_202	97%	53%	0.067	0.982	1.14	0.68	-	-	0	0	100%	1
6SLL_DAB_B_202	96%	65%	0.069	0.979	0.85	0.5	-	-	0	0	100%	1
6SL8_DAB_A_201	92%	49%	0.09	0.979	1.46	0.53	1	-	0	0	100%	1
4XMZ_DAB_A_910	89%	17%	0.097	0.976	0.96	2.6	-	2	0	0	100%	1
3KED_DAB_A_880	67%	31%	0.166	0.974	1.41	1.34	1	1	0	0	100%	1
5YU4_DAB_C_403	42%	46%	0.183	0.903	1.08	1	1	-	0	0	100%	1
3D3S_DAB_D_167	25%	6%	0.144	0.777	1.23	3.65	1	3	0	0	100%	1
6TWM_DAB_F_401	15%	56%	0.237	0.801	0.83	0.86	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.